UK pharma industry group ABPI announces new president
This article was originally published in SRA
Executive Summary
The Association of the British Pharmaceutical Industry has appointed John Kearney president of the association. He will take up office on 24 April. Mr Kearney replaces Jonathan Emms who is stepping down as president following a promotion within Pfizer which sees him relocating to the US1.
You may also be interested in...
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.
In Vivo’s 2024 Rising Leaders
The fifth annual listing of In Vivo’s Rising Leaders includes entrepreneurs and innovators from across the world who represent the next wave of creativity in health care.